Analyst Price Targets — JBS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 5, 2026 9:57 pm | — | UBS | $19.50 | $15.73 | TheFly | JBS initiated with a Buy at UBS |
| December 11, 2025 10:34 am | Guilherme Palhares | Banco Santander | $17.00 | $14.03 | TheFly | JBS upgraded to Outperform from Neutral at Grupo Santander |
| November 26, 2025 12:13 pm | — | Goldman Sachs | $18.50 | $14.53 | TheFly | JBS price target lowered to $18.50 from $21.10 at Goldman Sachs |
| October 28, 2025 11:21 am | — | Mizuho Securities | $20.00 | $13.16 | TheFly | JBS price target lowered to $20 from $22 at Mizuho |
Latest News for JBS
Citigroup Inc. lifted its position in shares of Jbs N.V. (NYSE: JBS) by 157.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 874,621 shares of the company's stock after buying an additional 534,526 shares during the period. Citigroup Inc.'s holdings in
PITTSBURGH, Feb. 09, 2026 (GLOBE NEWSWIRE) -- JBS Mental Health Authority (“JBS”), a provider of mental health services in Alabama,1 recently announced a cybersecurity incident, which impacted the personal information of over thirty thousand individuals. Lynch Carpenter, LLP is investigating claims against JBS related to this data breach. For an attorney to review your case, visit our site HERE .
New York State Common Retirement Fund acquired a new stake in Jbs N.V. (NYSE: JBS) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 246,000 shares of the company's stock, valued at approximately $3,673,000. A number of other large investors
Pre-Market Stock Futures: Futures are trading higher as we prepare to wrap up one of the worst trading weeks in some time. The song remains the same as the rotation out of the tech trade continues to gain strength. Toss in the weakness in cryptocurrencies, along with a renewed skepticism towards the asset, and the... Here Are Friday's Top Wall Street Analyst Research Calls: Amazon.com, Caterpillar, Estee Lauder,…
JBS N.V. remains fundamentally attractive and undervalued, with a Buy rating and a 2026 price target of $18.2/share. JBS's global protein leadership, strong FCF generation, and ongoing deleveraging underpin its investment case despite cyclical volatility. Valuation remains compelling at ~5x EV/EBITDA, well below peers like TSN and NSRGY, with Wall Street consensus supporting strong upside.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for JBS.
Senate Trading
No Senate trades found for JBS.
U.S. House Trading
No House trades found for JBS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.